CEO boosts Queensland`s commercialisation

The commercialisation arm of the University of Queensland’s Institute for Molecular Bioscience (IMB), IMBcom Pty Ltd, has announced the appointment of its new Chief Executive Officer.

Chair of IMBcom’s Board of Directors Emeritus Professor Ted Brown AC today (04/02/03) announced that Dr Peter Isdale is the new person responsible for the strategic oversight of the practical application of IMB`s world class research.

Professor Brown said Dr Isdale was highly respected in the marine science community and has strong links with government and industry as a result of his position as Business Director of the Australian Institute of Marine Science (AIMS).

“The Board is pleased to welcome Peter as CEO and a Director of IMBcom, and looks forward to working with him in building on the impressive start the company has made under the dynamic leadership of Professor Peter Andrews,” Professor Brown said.

“Peter is an inspirational, effective and understanding leader, qualities vital for a CEO in the current business climate, and the Board is confident IMBcom will expand its excellent and professional service in biotechnology commercialisation.”

CEO elect Dr Isdale said he was both excited and proud to be leading IMBcom at this critical period in the development of Queensland`s bioscience industry.

“The IMBcom team is about developing the outstanding commercial potential of IMB research, as well as promoting and rewarding a culture of entrepreneurship,” Dr Isdale said.

“Queensland has some of the best researchers in the world working at the IMB and IMBcom is integral to spinning off companies and developing strategic alliances with industry partners to enhance this research.”

IMB Director Professor John Mattick AO said the appointment of Dr Isdale was a coup for both IMBcom and the IMB due to his wealth of experience in commercialising scientific research.

“During his time at AIMS Peter was pivotal in spinning off biotechnology companies, building alliances, developing licensing agreements, as well as negotiating technology transfer arrangements,” Professor Mattick said.

“IMB research not only enhances our understanding of human and animal biology, but with the expertise of IMBcom, delivers important economic outcomes to Queensland and Australia.”

For photo, please contact Diana Lilley (telephone 07 3365 2753, email: d.lilley@uq.edu.au).

Media: for more information, contact Russell Griggs (07 3365 1805).